CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 3,054 enrolled
Drug / intervention
Fluarix™biological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00377611
NCT00377611Phase 4Completed
CompareCT.gov

A Study to Investigate the Incidence of Influenza and Influenza-related Complications, in Adults Between 50-64 Years and Elderly Adults 65 Years and Over Vaccinated With Fluarix™

GlaxoSmithKline·interventional·Posted Sep 18, 2006·Updated Oct 9, 2018

In Brief

A Phase 4 clinical trial evaluating Fluarix™ for Influenza. Completed, enrolled 3,054 participants across 37 sites in 4 countries.

Detailed Summary

A study to investigate the incidence of influenza and influenza-related complications, in adults between 50-64 years and elderly adults 65 years and over vaccinated with Fluarix™

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInfluenza
CountriesGermany, Netherlands, Poland, United States
Collaborators--

Timeline

Phase 4CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 18, 2006
Enrollment StartOct 5, 2006
Primary CompletionJun 20, 2007
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 19.8 years ago

Interventions

Fluarix™biological